Resources Contact Us Home
Oligoadenylate synthetase (OAS)

Image Number 2 for United States Patent #8133710.

The invention describes novel pharmaceutical compositions for the treatment of virus infections and cancer. The pharmaceutical compositions include mutant oligoadenylate synthetases (OAS) that have either enhanced cell permeability, reduced oxidative potential, improved antiviral activity, improved enzymatic activity, or absent enzymatic activity. The pharmaceutical compositions have improved drug properties and retain or have enhanced antiviral activity relative to their native forms. The pharmaceutical compositions further include chemically modified oligoadenylate synthetases, such chemical modifications being designed to increase serum stability and reduce immunogenicity in vivo. Such chemical modifications further increase drug stability and manufacturability in vitro. Compositions composed of more than ninety novel modifications are described. Also described are antibodies to polypeptides of the invention.

  Recently Added Patents
Methods and apparatus for clock signal synchronization in a configuration of series connected semiconductor devices
Gas cap removal tool
Retrievable outgoing audio messaging
Detection system and method for mobile device application
Glycosyltransferase promoter
Color stable manganese-doped phosphors
Messenger bag
  Randomly Featured Patents
Battery pack
Attachment for box making machine
Effective ophthalmic irrigation solution
Anchoring component
Method and apparatus for winding ring-shaped articles
Diabetes management system
Disk loader having a side air blast for proper bag presentation
Nitride semiconductor crystal with surface texture
Belt-type fixing device
Herniaria glabra plant named `Sea Foam`